Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2024
Poorly extractable and/or non- radiolabelled substances - Scientific guideline
Determining the fate of veterinary medicinal products in manure - Scientific guideline
Agenda - PDCO agenda of the 25-28 June 2024 meeting
Committee for Medicinal Products for Veterinary Use (CVMP): 18-20 June 2024, European Medicines Agency, Amsterdam, the Netherlands, from 18 June 2024 to 20 June 2024
Minutes of the CVMP meeting 18-19 June 2024
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2024 to 3 July 2024
Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 18, Status: Authorised
Chemistry of active substances (chemistry of new active substances) - Scientific guideline
Draft guideline on the chemistry of active substances - Revision 1